Research led by Korea University Ansan Hospital reports finding an association between moderate to severe obstructive sleep apnea and increased risk of cerebral microbleeds. Cerebral microbleeds ...

The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

With the recent trial launch of the federal Medicare GLP-1 Bridge program, American medicine has officially stepped into a ...

Tirzepatide reduced sleep apnea events and improved weight loss, reshaping treatment for nighttime breathing disorders.

Health Canada has approved an injection medication to treat severe obstructive sleep apnea in adults with obesity.

Moderate to severe obstructive sleep apnea (OSA) independently correlated with development of cerebral microbleeds seen on brain MRI. Cerebral microbleeds are considered an early marker of cerebral ...

Credit: Getty Images Obstructive sleep apnea may significantly increase the risk for coronary artery disease, atrial fibrillation, cerebrovascular accident, and congestive heart failure. Obstructive ...

Sleep apnea may affect more than sleep by influencing blood vessel health and erectile function, highlighting the importance ...

A systematic review and meta-analysis of 8 observational studies found that greater obstructive sleep apnea severity was ...

No smartwatch can actually diagnose sleep apnea, but some can track certain signs that might indicate you have the condition.